🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of acetaminophen, alleging the firms hid alleged dangers that the pain reliever presented to children's neurological development.

The court filing arrives four weeks after President Donald Trump publicized an unverified association between using Tylenol - alternatively called acetaminophen - during pregnancy and autism in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever approved for women during pregnancy, and Kenvue, which presently makes it.

In a official comment, he claimed they "betrayed America by profiting off of pain and pushing pills without regard for the potential hazards."

Kenvue states there is no credible evidence linking Tylenol to autism.

"These manufacturers misled for generations, deliberately risking numerous people to line their pockets," the attorney general, from the Republican party, declared.

Kenvue commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its website, the company also said it had "regularly reviewed the relevant science and there is lacking reliable evidence that demonstrates a established connection between taking paracetamol and autism."

Groups speaking for medical professionals and health professionals concur.

The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in acetaminophen - is one of the few options for expectant mothers to address pain and fever, which can present significant medical dangers if not addressed.

"In more than two decades of research on the consumption of paracetamol in gestation, zero credible investigations has successfully concluded that the use of paracetamol in any period of pregnancy results in neurodevelopmental disorders in young ones," the organization commented.

The court filing mentions recent announcements from the previous government in arguing the medication is reportedly hazardous.

In recent weeks, the former president raised alarms from public health officials when he instructed expectant mothers to "resist strongly" not to consume Tylenol when sick.

The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the consumption of acetaminophen, while also declaring that "a proven link" between the drug and autism spectrum disorder in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had promised in April to undertake "a massive testing and research effort" that would identify the source of autism in a matter of months.

But experts warned that identifying a unique factor of autism spectrum disorder - believed by scientists to be the result of a complicated interplay of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a form of enduring cognitive variation and condition that affects how individuals encounter and interact with the surroundings, and is identified using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is seeking the Senate - asserts the manufacturer and Johnson & Johnson "willfully ignored and attempted to silence the research" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "eliminate any marketing or advertising" that asserts acetaminophen is safe for expectant mothers.

This legal action mirrors the complaints of a assembly of parents of young ones with autism and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in two years ago.

The court rejected the case, stating research from the parents' expert witnesses was not conclusive.